Jiangsu Chinagreen Biological Technology Co Ltd
SZSE:300970
Jiangsu Chinagreen Biological Technology Co Ltd
SZSE:300970
Price:
12.53 CNY
3.21%
Market Closed
Updated:
Apr 29, 2024
Income Statement
Earnings Waterfall
Jiangsu Chinagreen Biological Technology Co Ltd
Jiangsu Chinagreen Biological Technology Co Ltd
|
Revenue
|
974.9m
CNY
|
|
Cost of Revenue
|
-792.4m
CNY
|
|
Gross Profit
|
182.5m
CNY
|
|
Operating Expenses
|
-92.5m
CNY
|
|
Operating Income
|
90m
CNY
|
|
Other Expenses
|
-2.9m
CNY
|
|
Net Income
|
87.1m
CNY
|
Income Statement
Jiangsu Chinagreen Biological Technology Co Ltd
Jiangsu Chinagreen Biological Technology Co Ltd
Currency: CNY
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue |
587
N/A
|
741
+26%
|
609
-18%
|
570
-6%
|
564
-1%
|
550
-3%
|
578
+5%
|
610
+5%
|
631
+4%
|
724
+15%
|
752
+4%
|
913
+22%
|
985
+8%
|
975
-1%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(418)
|
(533)
|
(443)
|
(453)
|
(481)
|
(505)
|
(540)
|
(576)
|
(592)
|
(608)
|
(633)
|
(674)
|
(726)
|
(792)
|
|
| Gross Profit |
170
N/A
|
208
+23%
|
166
-20%
|
117
-30%
|
83
-29%
|
45
-46%
|
38
-14%
|
34
-11%
|
39
+15%
|
116
+196%
|
119
+3%
|
239
+101%
|
259
+8%
|
183
-30%
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(32)
|
(40)
|
(32)
|
(28)
|
(27)
|
(28)
|
(34)
|
(34)
|
(35)
|
(40)
|
(51)
|
(64)
|
(74)
|
(93)
|
|
| Selling, General & Administrative |
(28)
|
(36)
|
(30)
|
(31)
|
(33)
|
(35)
|
(34)
|
(40)
|
(38)
|
(41)
|
(46)
|
(58)
|
(64)
|
(81)
|
|
| Research & Development |
(9)
|
(11)
|
(8)
|
(9)
|
(8)
|
(9)
|
(8)
|
(8)
|
(11)
|
(13)
|
(13)
|
(16)
|
(17)
|
(17)
|
|
| Depreciation & Amortization |
0
|
0
|
(4)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
|
| Other Operating Expenses |
5
|
7
|
10
|
11
|
14
|
15
|
13
|
14
|
14
|
13
|
14
|
9
|
7
|
5
|
|
| Operating Income |
137
N/A
|
168
+23%
|
134
-20%
|
89
-34%
|
56
-37%
|
16
-71%
|
5
-71%
|
(0)
N/A
|
4
N/A
|
76
+1 828%
|
68
-10%
|
175
+156%
|
185
+6%
|
90
-51%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
(3)
|
(3)
|
1
|
(7)
|
(3)
|
2
|
13
|
14
|
14
|
13
|
14
|
11
|
8
|
6
|
|
| Non-Reccuring Items |
(1)
|
(1)
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(5)
|
(7)
|
|
| Total Other Income |
(1)
|
(1)
|
(2)
|
0
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Pre-Tax Income |
132
N/A
|
163
+23%
|
132
-19%
|
82
-38%
|
52
-36%
|
17
-67%
|
17
-3%
|
13
-24%
|
17
+31%
|
87
+427%
|
80
-8%
|
184
+130%
|
187
+2%
|
88
-53%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(1)
|
(0)
|
(1)
|
(1)
|
(2)
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
132
|
163
|
132
|
82
|
52
|
18
|
16
|
12
|
16
|
87
|
78
|
181
|
185
|
85
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
(1)
|
(0)
|
(0)
|
1
|
0
|
1
|
2
|
|
| Net Income (Common) |
132
N/A
|
163
+23%
|
133
-19%
|
82
-38%
|
53
-36%
|
18
-66%
|
16
-13%
|
11
-26%
|
16
+38%
|
87
+449%
|
78
-10%
|
182
+132%
|
185
+2%
|
87
-53%
|
|
| EPS (Diluted) |
1.51
N/A
|
1.86
+23%
|
3.03
+63%
|
1.87
-38%
|
0.45
-76%
|
0.15
-67%
|
0.14
-7%
|
0.09
-36%
|
0.13
+44%
|
0.74
+469%
|
0.67
-9%
|
1.56
+133%
|
1.59
+2%
|
0.75
-53%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
